| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-07 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-07 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-07 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-07 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-07 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.26 | 1e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-06 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-06 |